货号 | 产品名 | 纯度 | ||
---|---|---|---|---|
A1251842 | 现货 | 促 |
LP-935509
LP-935509是一种口服有效的、选择性、ATP竞争性的接头蛋白-2相关激酶1 (AAK1) 抑制剂,IC50为3.3 nM。该化合物具有镇痛活性,并在神经性疼痛和SARS-CoV-2研究中具有潜在应用价值。 |
99%+ |
A689142 | 现货 |
7-Aminocoumarin
|
97% | |
A1671242 |
SGC-AAK1-1N
|
98% | ||
A2417241 |
AAK1-IN-2 TFA
|
98% | ||
A1339752 |
BMT-124110
|
98% | ||
A1531989 |
BMS-911172
|
98% | ||
A1551139 |
AAK1-IN-5
|
98% | ||
A1501760 |
BMS-986176
|
98% | ||
A1602033 |
AAK1-IN-4
|
98% | ||
A1601883 |
AAK1-IN-3 TFA
|
98% | ||
A1602051 |
AAK1-IN-2
|
98% | ||
A1601922 |
AAK1-IN-3
|
98% | ||
A2021721 |
LP-922761 hydrate
|
98% | ||
A1967328 |
GSK-3β inhibitor 13
|
98% | ||
A1702848 |
BMT-090605 HCl
|
98% | ||
A1328049 |
BMT-090605
|
98% | ||
A2792186 |
LP-935509
|
99% |